MAA
IMGN

Managed Account Advisors’s Immunogen Inc IMGN Stock Holding History

Managed Account Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$12.7M Buy
881,007
+41,125
+5% +$452K 0.01% 966
2015
Q1 		$7.52M Buy
839,882
+304,346
+57% +$2.2M 0.01% 1217
2014
Q4 		$3.27M Buy
535,536
+49,941
+10% +$457K ﹤0.01% 1593
2014
Q3 		$5.14M Buy
485,595
+109,606
+29% +$1.24M 0.01% 1360
2014
Q2 		$4.46M Buy
375,989
+50,304
+15% +$631K 0.01% 1432
2014
Q1 		$4.86M Buy
325,685
+72,228
+28% +$1.14M 0.01% 1333
2013
Q4 		$3.72M Buy
253,457
+75,647
+43% +$1.16M 0.01% 1443
2013
Q3 		$3.03M Buy
177,810
+18,400
+12% +$323K ﹤0.01% 1491
2013
Q2 		$2.64M Buy
+159,410
New +$2.58M ﹤0.01% 1509

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Managed Account Advisors's IMGN Position: Q2 2015 in Review

Managed Account Advisors increased its Immunogen Inc (IMGN) stake by 4.9% in Q2 2015, buying an estimated $452K and bringing the position to 881,007 shares worth $12.7M. The position accounts for 0.01% of the portfolio, ranked #966.

Managed Account Advisors first reported a position in IMGN in Q2 2013 and has held it in 9 quarters since. 140 funds tracked by Wall St. Rank hold IMGN as of Q2 2015.

  • Managed Account Advisors held 881,007 shares of Immunogen Inc worth $12.7M as of Q2 2015.
  • Managed Account Advisors bought 41,125 Immunogen Inc shares in Q2 2015, an estimated $452K.
  • Immunogen Inc made up 0.01% of Managed Account Advisors's portfolio in Q2 2015, its #966 holding.
  • Managed Account Advisors first reported a position in Immunogen Inc in Q2 2013 and has held it in 9 quarters since.
  • 140 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.